Change in Director / Key Managerial Personnel
Nature of change: Re-appointment and continuation as Whole-time Director beyond age 70.
Name and DIN: Mr. Mohan Kumar Rayana (DIN: 07878975)
Effective date and tenure: From 21st August 2026 up to 20th August 2031 (5-year term).
Brief profile: Graduated in pharmacy (B. Pharm) from University of Mumbai. Has over 25 years of experience as a business and management advisor, including with Wanbury in an advisory role. Brings more than two decades of pharmaceutical industry experience. Expertise includes Business Strategy, general management, talent enrichment at key senior positions, team building, acquisitions and mergers, problem solving, fund raising, and debt settlement.
Confirmation of eligibility: Verified by the Nomination and Remuneration Committee. Not debarred from holding office of director by virtue of any order of SEBI or any other authority.
Relationship with other directors: Not related to any of the Directors of the Company.
Key Financial or Operational Approvals
Cost Auditor Appointment: The AGM approved the appointment and ratification of remuneration payable to M/s. ABK & Associates, Cost Accountant (Firm Registration No. 000036), Mumbai, as Cost Auditor of the Company for conducting cost audit for the Financial Year 2026-2027.
Director Re-appointment: The AGM approved the re-appointment of Mr. Mohan Kumar Rayana as Whole-time Director and his continuation beyond the age of 70 years.
Any Other Material Information
Regulatory Compliance: Disclosures provided pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 and SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.
Cost Auditor Details: M/s. ABK & Associates is a firm of Cost Accountants established in 1989 with head office in Mumbai and branch offices in Indore, Delhi, and Vadodara. Has over 35 years of professional experience providing services including Cost Audit, Internal Audit, Management Consultancy, Cost Consultancy, GST Advisory, Project Finance, Budgetary Control, Standard Costing, MIS and Development, and Strategic Business Advisory. Serves clients across automobiles, engineering, petroleum, power, infrastructure, pharmaceuticals, textiles, FMCG, healthcare, and chemicals industries. Not related to any Directors of the Company and not debarred from holding office of auditor by any regulatory authority.
Meeting Details: The 38th Annual General Meeting was held on Thursday, September 24, 2026, commencing at 11:30 a.m. and concluding at 12:35 p.m.